Blocking EZH2 activity in some human cancer cell lines, including GBM cells, inhibits growth [27,28,29], suggesting unchecked EZH2 activity causes H3K27 hypermethylation and tumor-suppressor inhibition [30]. Here, EZH2 is linked to glioblastoma.